These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1599518)

  • 21. Methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Sinnett MJ; Groff GD; Raddatz DA; Franck WA; Bertino JS
    J Rheumatol; 1989 Jun; 16(6):745-8. PubMed ID: 2674426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients.
    Herman RA; Veng-Pedersen P; Hoffman J; Koehnke R; Furst DE
    J Pharm Sci; 1989 Feb; 78(2):165-71. PubMed ID: 2715941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis.
    Vakily M; Amer F; Kukulka MJ; Andhivarothai N
    J Clin Pharmacol; 2005 Oct; 45(10):1179-86. PubMed ID: 16172183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral to subcutaneous methotrexate dose-conversion strategy in the treatment of rheumatoid arthritis.
    Schiff MH; Sadowski P
    Rheumatol Int; 2017 Feb; 37(2):213-218. PubMed ID: 28012023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal administration and dosage of methotrexate.
    Braun J
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S46-51. PubMed ID: 21044433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U; Heuer KU
    Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of methotrexate in rheumatoid arthritis: therapeutic implications].
    Bannwarth B; Péhourcq F; Lequen L
    Therapie; 1997; 52(2):129-32. PubMed ID: 9231507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biliary elimination of low-dose methotrexate in humans.
    Nuernberg B; Koehnke R; Solsky M; Hoffman J; Furst DE
    Arthritis Rheum; 1990 Jun; 33(6):898-902. PubMed ID: 2363742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate bioavailability after oral and intramuscular administration in children.
    Teresi ME; Crom WR; Choi KE; Mirro J; Evans WE
    J Pediatr; 1987 May; 110(5):788-92. PubMed ID: 3471936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of food on methotrexate absorption.
    Hamilton RA; Kremer JM
    J Rheumatol; 1995 Apr; 22(4):630-2. PubMed ID: 7791153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers.
    Kozloski GD; De Vito JM; Kisicki JC; Johnson JB
    Arthritis Rheum; 1992 Jul; 35(7):761-4. PubMed ID: 1622413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of methotrexate administered by intramuscular and subcutaneous injections in patients with rheumatoid arthritis.
    Brooks PJ; Spruill WJ; Parish RC; Birchmore DA
    Arthritis Rheum; 1990 Jan; 33(1):91-4. PubMed ID: 2302272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.
    Goodman SM; Cronstein BN; Bykerk VP
    Clin Exp Rheumatol; 2015; 33(2):272-8. PubMed ID: 25536122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral Methotrexate in split dose weekly versus oral or parenteral Methotrexate once weekly in Rheumatoid Arthritis: a short-term study.
    Dhaon P; Das SK; Srivastava R; Agarwal G; Asthana A
    Int J Rheum Dis; 2018 May; 21(5):1010-1017. PubMed ID: 27455886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis.
    Furst DE
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():11-4. PubMed ID: 3913770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aspirin alters methotrexate disposition in rheumatoid arthritis patients.
    Stewart CF; Fleming RA; Germain BF; Seleznick MJ; Evans WE
    Arthritis Rheum; 1991 Dec; 34(12):1514-20. PubMed ID: 1747136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.